Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Contemp Clin Trials. 2020 Nov 24;100:106228. doi: 10.1016/j.cct.2020.106228

Table 4 -.

Determination of Symptom Level (2-week recall for symptoms and activity limitation)

Symptom Level # days with wheezing, or tightness in the chest or cough / two weeks and at least minimal limitation of activity # days with rescue albuterol use/ two weeks # nights of sleep disruption due to wheezing, or tightness in the chest or cough / two weeks # nights use of albuterol for awakening / two weeks Courses of systemic steroids for respiratory needs since last assessment
Well Controlled (Symptom level 1) 0–4 days 0–4 days 0–1 night 0–1 night 0
Not Well Controlled (Symptom level 2) ≥5 ≥5 ≥2 nights ≥2 nights ≥1